Corteva (NYSE:CTVA) Price Target Raised to $90.00 at Deutsche Bank Aktiengesellschaft

Corteva (NYSE:CTVA) had its price objective boosted by Deutsche Bank Aktiengesellschaft from $85.00 to $90.00 in a report published on Thursday,MarketScreener reports. The brokerage currently has a buy rating on the stock.

A number of other equities analysts also recently commented on the company. Wolfe Research increased their price objective on Corteva from $80.00 to $81.00 and gave the stock an “outperform” rating in a report on Friday, January 16th. Rothschild & Co Redburn dropped their price target on shares of Corteva from $71.00 to $65.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 11th. BNP Paribas Exane lifted their price objective on shares of Corteva from $70.00 to $72.00 and gave the company a “neutral” rating in a research note on Monday, November 17th. UBS Group lowered their target price on shares of Corteva from $85.00 to $81.00 and set a “buy” rating on the stock in a research report on Thursday, October 30th. Finally, Mizuho upped their price target on Corteva from $78.00 to $80.00 and gave the stock an “outperform” rating in a research note on Friday, January 16th. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $82.37.

Corteva Stock Up 1.6%

Corteva stock traded up $1.14 during trading hours on Thursday, hitting $73.61. The company had a trading volume of 90,869 shares, compared to its average volume of 3,922,674. The firm’s fifty day moving average is $68.72 and its 200-day moving average is $68.43. The firm has a market capitalization of $49.74 billion, a P/E ratio of 46.45, a price-to-earnings-growth ratio of 1.86 and a beta of 0.75. Corteva has a fifty-two week low of $53.40 and a fifty-two week high of $77.41. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 1.07.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.22. The business had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. Corteva’s revenue for the quarter was down 1.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts forecast that Corteva will post 2.96 earnings per share for the current year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 1.0%. The ex-dividend date is Monday, March 2nd. Corteva’s dividend payout ratio is presently 45.57%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Gladwyn Financial Advisors Inc. acquired a new position in Corteva in the 2nd quarter valued at approximately $25,000. Total Investment Management Inc. bought a new position in shares of Corteva during the 2nd quarter worth about $27,000. Activest Wealth Management increased its stake in Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after acquiring an additional 200 shares during the period. Curat Global LLC raised its position in Corteva by 93.7% in the second quarter. Curat Global LLC now owns 370 shares of the company’s stock worth $28,000 after purchasing an additional 179 shares in the last quarter. Finally, JPL Wealth Management LLC bought a new position in Corteva during the third quarter worth about $25,000. Institutional investors own 81.54% of the company’s stock.

Corteva News Summary

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Multiple banks raised price targets and kept bullish ratings, increasing buy-side momentum. Deutsche Bank raised its target to $90 and maintained a “buy” rating (largest upside call among the recent raises). Deutsche Bank raises target to $90
• Positive Sentiment: Wolfe Research bumped its target to $86 and reiterated an “outperform” rating, signaling a roughly mid‑teens upside vs. current levels. Wolfe Research raises target to $86
• Positive Sentiment: RBC increased its price target to $89 and kept an “outperform” rating, adding to the cluster of analysts signaling ~20%+ upside potential. RBC raises target to $89
• Neutral Sentiment: Aggregate analyst view remains mildly constructive — broker consensus is a “Moderate Buy,” reinforcing the message of multiple target hikes but not an across‑the‑board upgrade. Consensus Moderate Buy
• Neutral Sentiment: Coverage pieces note the company’s bull case could change depending on outcomes from a Bayer settlement and licensing shifts — a potential catalyst but with uncertain timing and impact. Bull case and Bayer settlement
• Negative Sentiment: JPMorgan cut Corteva from “overweight” to “neutral” (though they slightly raised their PT to $77), flagging valuation and limited near‑term upside — this downgrade tempers some of the recent bullish analyst noise. JPMorgan downgrade
• Negative Sentiment: Corteva’s Q4 results missed revenue estimates (seasonal timing and lower crop protection/seed demand) and the company reported a wider loss, which pushed shares lower after hours — this is the primary near‑term operational weakness investors are weighing. Q4 revenue miss and after‑hours drop

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.